These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29624239)

  • 21. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L; Mann AKP; Liu Z; Milewski M; Zhang S; Ren J; Dewitt K; Hermans A; Cote A
    Int J Pharm; 2019 Mar; 559():147-155. PubMed ID: 30654058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubility and dissolution rate enhancement of ibuprofen by co-milling with polymeric excipients.
    Hussain A; Smith G; Khan KA; Bukhari NI; Pedge NI; Ermolina I
    Eur J Pharm Sci; 2018 Oct; 123():395-403. PubMed ID: 30076953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solubilizing excipients in oral and injectable formulations.
    Strickley RG
    Pharm Res; 2004 Feb; 21(2):201-30. PubMed ID: 15032302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
    Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
    Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
    Yuvaraja K; Khanam J
    J Pharm Biomed Anal; 2014 Aug; 96():10-20. PubMed ID: 24705456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical considerations in development of solid dosage forms that contain cyclodextrin.
    Miller LA; Carrier RL; Ahmed I
    J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vinylpyrrolidone polymers on the solubility and supersaturation of drugs; a study using the Cheqsol method.
    Fornells E; Fuguet E; Mañé M; Ruiz R; Box K; Bosch E; Ràfols C
    Eur J Pharm Sci; 2018 May; 117():227-235. PubMed ID: 29481859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrogel-based drug carriers for controlled release of hydrophobic drugs and proteins.
    Peng K; Tomatsu I; Kros A
    J Control Release; 2011 Nov; 152 Suppl 1():e72-4. PubMed ID: 22195937
    [No Abstract]   [Full Text] [Related]  

  • 29. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
    Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
    J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
    Kumar S; Bhargava D; Thakkar A; Arora S
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microenvironmental pH modulation in solid dosage forms.
    Badawy SI; Hussain MA
    J Pharm Sci; 2007 May; 96(5):948-59. PubMed ID: 17455349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach.
    Bohr A; Boetker JP; Rades T; Rantanen J; Yang M
    Curr Pharm Des; 2014; 20(3):325-48. PubMed ID: 23651398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs.
    Hu J; Johnston KP; Williams RO
    Drug Dev Ind Pharm; 2004 Mar; 30(3):233-45. PubMed ID: 15109023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melt extrusion with poorly soluble drugs.
    Shah S; Maddineni S; Lu J; Repka MA
    Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of therapeutic delivery using conducting polymers.
    Poole-Warren L; Goding J
    Ther Deliv; 2012 Apr; 3(4):421-7. PubMed ID: 22834074
    [No Abstract]   [Full Text] [Related]  

  • 37. Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals.
    Xia D; Gan Y; Cui F
    Curr Pharm Des; 2014; 20(3):408-35. PubMed ID: 23651396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of polymers enabling nano-comminution of water-insoluble drugs.
    Lee J; Choi JY; Park CH
    Int J Pharm; 2008 May; 355(1-2):328-36. PubMed ID: 18261866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microencapsulation by solvent evaporation: state of the art for process engineering approaches.
    Li M; Rouaud O; Poncelet D
    Int J Pharm; 2008 Nov; 363(1-2):26-39. PubMed ID: 18706988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.